XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of stock based compensation expense

Stock-based compensation expense included in the Company's consolidated financial statements for the three and six months ended June 30, 2019 and July 1, 2018 was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

2019

 

 

July 1,

2018

 

 

June 30,

2019

 

 

July 1,

2018

 

Cost of revenue

 

$

18

 

 

$

35

 

 

$

44

 

 

$

69

 

Research and development

 

 

532

 

 

 

207

 

 

 

1,187

 

 

 

390

 

Selling, general and administrative

 

 

241

 

 

 

237

 

 

 

511

 

 

 

452

 

Total costs and expenses

 

$

791

 

 

$

479

 

 

$

1,742

 

 

$

911

 

Summary of the activity in the shares available for grant

The following table summarizes the activity in the shares available for grant under the 2019 Plan and 2009 Plan during the six months ended June 30, 2019 (in thousands):

 

 

Shares available for grants

 

 

2019 Plan

 

 

2009 Plan

 

Balance at December 30, 2018

 

-

 

 

 

6,760

 

Authorized

 

5,000

 

 

 

-

 

RSUs granted

 

(794

)

 

 

(3,355

)

RSUs forfeited or expired

 

184

 

 

 

762

 

Options forfeited

 

15

 

 

 

20

 

Plan shares expired

 

-

 

 

 

(4,187

)

Balance at June 30, 2019

 

4,405

 

 

 

-

 

Summary of stock options outstanding and stock option activity and the related weighted average exercise price

The following table summarizes stock options outstanding and stock option activity under the 2009 Plan and the 2019 Plan, and the related weighted average exercise price, for the six months ended June 30, 2019:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

(in thousands)

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Balance outstanding at December 30, 2018

 

 

3,201

 

 

$

2.18

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(580

)

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(4

)

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding at June 30, 2019

 

 

2,617

 

 

$

2.29

 

 

 

3.97

 

 

$

-

 

Exercisable at June 30, 2019

 

 

2,383

 

 

$

2.43

 

 

 

3.65

 

 

$

-

 

Vested and expected to vest at June 30, 2019

 

 

2,594

 

 

$

2.31

 

 

 

3.94

 

 

$

-

 

Summary of activity for RSUs and PRSUs

A summary of activity for the Company's RSUs for the six months ended June 30, 2019 is as follows:

 

 

 

RSUs & PRSUs Outstanding

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

 

 

 

Nonvested at December 30, 2018

 

 

2,570

 

 

$

1.23

 

Granted

 

 

4,148

 

 

 

0.85

 

Vested

 

 

(926

)

 

 

1.08

 

Forfeited

 

 

(401

)

 

 

0.96

 

Nonvested at June 30, 2019

 

 

5,391

 

 

$

1.04

 

Summary of the fair value of rights issued pursuant to ESPP

The fair value of rights issued pursuant to the Company's 2009 ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

2019

 

 

July 1,

2018

 

 

June 30,

2019

 

 

July 1,

2018

 

Expected term (months)

 

 

6.00

 

 

 

6.0

 

 

 

6.00

 

 

 

6.00

 

Risk-free interest rate

 

 

2.40

%

 

 

2.09

%

 

 

2.40

%

 

 

2.09

%

Volatility

 

 

53.77

%

 

 

44.76

%

 

 

53.77

%

 

 

44.76

%

Dividend yield